By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cyclacel Limited 

James Lindsay Place
Dundee Technopole
Dundee    DD1 5JJ  United Kingdom
Phone: 44-1382-206-062 Fax: 44-1382-206-067


Company News
Cyclacel Limited (CYCC) & Manros Therapeutics Announce Licensing & Supply Agreement Regarding Development Of Seliciclib In Cystic Fibrosis 6/29/2015 7:31:13 AM
Cyclacel Limited (CYCC) Answers Celgene (CELG)'s Declaratory Judgment Complaint and Counterclaims for Infringement of Four Cyclacel Patents 6/18/2010 9:13:42 AM
Cyclacel Limited (CYCC) Receives Complaint Filed by Celgene Corporation (CELG) Seeking to Avoid Certain Cyclacel Patents 5/3/2010 10:22:14 AM
Cyclacel Limited (CYCC) Announces Publication of Peer-Reviewed Journal Article Describing the Mechanism of Action of Seliciclib 12/30/2009 10:08:36 AM
Cyclacel Limited (CYCC) Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 American Society of Hematology Annual Meeting 12/7/2009 8:48:59 AM
Cyclacel Limited (CYCC) to Present At Annual Needham Biotechnology and Medical Technology Conference 6/9/2009 9:24:37 AM
Cyclacel Limited (CYCC) Advances Oral Sapacitabine Pivotal Trial Plan in Hematological Malignancies 2/6/2009 6:36:29 AM
Cyclacel Limited (CYCC) Announces Completion of Enrollment in Phase 2 Trial of Sapacitabine in Elderly AML 10/9/2008 11:12:41 AM
Cyclacel Limited (CYCC) to Present at Annual Needham Biotechnology & Medical Technology Conference 6/5/2008 12:58:37 PM
Cyclacel Limited (CYCC) Reports Second Quarter 2006 Financial Results 8/15/2006 10:57:50 AM